NRC expected to issue Mo-99 facility license for Shine in 2021

May 13, 2020, 9:10PMNuclear News

Shine Medical Technologies, which is building a medical isotope production facility in Janesville, Wis., said on May 11 that it expects to have an operating license issued by the Nuclear Regulatory Commission by October 2021. Shine’s application seeking approval to operate the facility, which will produce isotopes including molybdenum-99, was accepted and docketed by the NRC last October. Mo-99, the precursor to technetium-99m, is used in more than 40 million medical patient procedures every year.

To continue reading, log in or create a free account!

Related Articles

Diablo Canyon gets key state approval

December 16, 2025, 7:00AMNuclear News

Pacific Gas & Electric has announced that the California Coastal Commission, the state agency in charge of protecting California’s roughly 840 miles of coastline, unanimously voted to...

Nieh sworn in to NRC

December 9, 2025, 7:04AMNuclear News

The Nuclear Regulatory Commission is now back up to four commissioners. Following a 66–32 confirmation vote in the U.S. Senate last month, Ho Nieh was officially sworn in last week.He fills...

Nieh confirmed for the NRC

November 19, 2025, 3:00PMNuclear News

Earlier today, the U.S. Senate officially confirmed Ho Nieh in a 66–32 vote to serve as a commissioner on the U.S. Nuclear Regulatory Commission through the remainder of a term that will...